BSE filing, NSE: ZYDUSLIFE. Summary written from the filing by ALFA Finder's alert engine.
Zydus Lifesciences Ltd: key numbers
- Share price
- ₹1,175.50
- Market cap
- ₹1,18,283 Cr
- Revenue (annual)
- ₹27,148 Cr
- Net profit (annual)
- ₹5,040 Cr
- P/E (TTM)
- 26.2×Sector 46.5×
- Promoter holding
- 75.01%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Lifesciences Ltd
All →Zydus Lifesciences Partnership
Zydus Lifesciences' division Zylidac Bio partnered with Prolific Machines to scale their next-generation biologics manufacturing platform for GMP production.
Zydus Lifesciences Regulatory Approval
Zydus Lifesciences received USFDA approval for its Estradiol-Levonorgestrel Transdermal System ANDA, designated as a CGT. The product is eligible for 180-day exclusivity upon first commercial marketing.
Zydus Lifesciences Other Announcement
Zydus Lifesciences Limited has been assigned an ESG rating of 71 by NSRAL for the financial year 2026. This unsolicited rating reflects the company's sustainability performance.
Zydus Lifesciences Capacity Expansion: ₹190 Cr Investment
Zydus' JV with Sunshine Healthcare signed a BOI agreement to establish a pharma plant in Sri Lanka. Investment exceeds USD 20 million (~₹190 Cr), targeting 2028.
- Value
- ₹190.0 Cr
Zydus Lifesciences Business Update
Zydus Lifesciences presented post-hoc analysis from its EPICS-III clinical trial for Saroglitazar at ACG 2026. The drug remains under regulatory review for PBC treatment.
Zydus Lifesciences Other Announcement
Zydus Lifesciences Limited submitted the quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming share dematerialization compliance for the quarter ended September 30, 2026.
Other board meeting date announcements
All →ESDS Software Solution Board Meeting Date
ESDS Software Solution will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for Q2 and half-year. This is a prior intimation of a future meeting with no decision yet taken.
Mrugesh Trading Board Meeting Date
Mrugesh Trading will hold a board meeting on 31 October 2026 to consider unaudited Q2 and half-year results. This is a prior intimation of a future meeting, with no decision yet taken.
Add-Shop E-Retail Board Meeting Date
Add-Shop E-Retail will hold a board meeting on 2 November 2026 to consider unaudited quarterly and half-year results. Video conferencing is the mode.
Polymechplast Machines Board Meeting Date
Polymechplast Machines will hold a board meeting on November 4, 2026 to consider unaudited half-year results. Trading window stays closed until 48 hours after the results.
Scarnose International Board Meeting Date
Scarnose International will hold a board meeting on 2 November 2026 to consider unaudited half-year results. The agenda remains proposed until the meeting occurs.
Nitin Castings Board Meeting Date
Nitin Castings will hold a board meeting on 2 November 2026 to consider September 2026 half-year unaudited results. Trading window stays closed until results are declared.